AI assistant
GlaxoSmithKline PLC — Remuneration Information 2018
Nov 27, 2018
5262_rns_2018-11-27_a19ef3f7-21d4-4f76-bb7f-9ed3eef1abb1.html
Remuneration Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 6693I
GlaxoSmithKline PLC
27 November 2018
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 27 November 2018
| Name of applicant: | GlaxoSmithKline plc | |||
| Name of scheme: | GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan | |||
| Period of return: | From: | 1 May 2018 | To: | 31 October 2018 |
| Balance of unallotted securities under scheme(s) from previous return: | Previous balance: 33,863* Restated balance: -27,669 |
|||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 575,000 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 547,331 | |||
| Name of contact: | Victoria Whyte |
| Telephone number of contact: | 020 8047 5000 |
*Due to clerical error the opening balance has been restated.
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 27 November 2018
| Name of applicant: | GlaxoSmithKline plc | |||
| Name of scheme: | GlaxoSmithKline Share Option Plan - Ordinary Shares | |||
| Period of return: | From: | 1 May 2018 | To: | 31 October 2018 |
| Balance of unallotted securities under scheme(s) from previous return: | Previous balance: 2,693,951* Restated balance: 2,755,483 |
|||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 532,131 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 2,223,352 | |||
| Name of contact: | Victoria Whyte |
| Telephone number of contact: | 020 8047 5000 |
*Due to clerical error the opening balance has been restated.
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 27 November 2018
| Name of applicant: | GlaxoSmithKline plc | |||
| Name of scheme: | GlaxoSmithKline Share Option Plan - ADS | |||
| Period of return: | From: | 1 May 2018 | To: | 31 October 2018 |
| Balance of unallotted securities under scheme(s) from previous return: | 7,909,994 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 573,898 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 7,336,096 | |||
| Name of contact: | Victoria Whyte |
| Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 27 November 2018
| Name of applicant: | GlaxoSmithKline plc | |||
| Name of scheme: | GlaxoSmithKline plc Share Save Plan 2012 | |||
| Period of return: | From: | 1 May 2018 | To: | 31 October 2018 |
| Balance of unallotted securities under scheme(s) from previous return: | 827,306 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 5,000,000 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 154,683 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 5,672,623 | |||
| Name of contact: | Victoria Whyte |
| Telephone number of contact: | 020 8047 5000 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
BLRZMMZMKNZGRZM